序号 | 受理号 | 药品名称 | 药品类型 | 申请类型 | 注册分类 | 企业名称 | 承办日期 |
1 | JXHS2300088 | 来那帕韦片 | 化药 | 进口 | 5.1 | Gilead Sciences Ireland UC;Rottendorf Pharma GmbH;Gilead Sciences Shanghai Pharmaceutical Technology Co., Ltd.; | 2023-9-23 |
2 | JXHL2300244 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
3 | JXHL2300243 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
4 | JXHL2300242 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
5 | JXHL2300241 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
6 | JXHL2300240 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
7 | JXHL2300239 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-22 |
8 | JTH2300230 | 氟维司群 | 进口 | 化药 | Ajinomoto Omnichem N.V.;AstraZeneca AB;阿斯利康投资(中国)有限公司; | 2023-9-22 | |
9 | JYHS2300121 | 溴吡斯的明缓释片 | 化药 | 进口 | 5.2 | Alvogen, Inc.;Norwich Pharmaceuticals Inc;Beijing RarePlus MedTech Co., Ltd; | 2023-9-22 |
10 | JXHL2300238 | CFT8919片 | 化药 | 进口 | 1 | C4 Therapeutics, Inc.;Betta Pharmaceuticals Co., Ltd.; | 2023-9-22 |
11 | JXHL2300237 | CFT8919片 | 化药 | 进口 | 1 | C4 Therapeutics, Inc.;Betta Pharmaceuticals Co., Ltd.; | 2023-9-22 |
12 | JXHS2300087 | 甲磺酸奥希替尼片 | 化药 | 进口 | 2.4 | AstraZeneca AB;AstraZeneca AB;AstraZeneca Investment (China) Co., Ltd.; | 2023-9-21 |
13 | JXHS2300086 | 甲磺酸奥希替尼片 | 化药 | 进口 | 2.4 | AstraZeneca AB;AstraZeneca AB;AstraZeneca Investment (China) Co., Ltd.; | 2023-9-21 |
14 | JXHS2300085 | 雌二醇透皮喷雾剂 | 化药 | 进口 | 5.1 | Gedeon Richter Plc.;Gedeon Richter Romania S.A.;Gedeon Richter Pharmaceutical (China)Company Limited; | 2023-9-21 |
15 | JYHS2300120 | 米氮平片 | 化药 | 进口 | 5.2 | Mylan Laboratories Limited;Mylan Laboratories Limited;Viatris Pharmaceuticals Co., Ltd.; | 2023-9-20 |
16 | JYHS2300119 | 米氮平片 | 化药 | 进口 | 5.2 | Mylan Laboratories Limited;Mylan Laboratories Limited;Viatris Pharmaceuticals Co., Ltd.; | 2023-9-20 |
17 | JYHS2300118 | 吗替麦考酚酯胶囊 | 化药 | 进口 | 5.2 | Mylan Laboratories Limited;Mylan Laboratories Limited;Viatris Pharmaceuticals Co., Ltd.; | 2023-9-20 |
18 | JXHS2300084 | 恩扎卢胺软胶囊 | 化药 | 进口 | 5.1 | Astellas Pharma Europe B.V.;Catalent Pharma Soluti**, LLC;Astellas Pharma China, Inc.; | 2023-9-19 |
19 | JXHL2300236 | 磷酸芦可替尼乳膏 | 化药 | 进口 | 5.1 | Incyte Biosciences Distribution B.V.;/; | 2023-9-19 |
20 | JXHL2300235 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-19 |
21 | JXHL2300234 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-19 |
22 | JXHL2300233 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-19 |
23 | JXHL2300232 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-19 |
24 | JXHL2300231 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-18 |
25 | JXHL2300230 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-18 |
26 | JXHL2300229 | BI 456906 注射液 | 化药 | 进口 | 1 | Boehringer Ingelheim International GmbH;Boehringer Ingelheim (China) Investment Co.,Ltd.; | 2023-9-18 |
27 | JXHL2300228 | LOXO-435片 | 化药 | 进口 | 1 | Eli Lilly and Company;Lilly Suzhou Pharmaceutical Co., Ltd.; | 2023-9-18 |
28 | JXHL2300227 | LOXO-435片 | 化药 | 进口 | 1 | Eli Lilly and Company;Lilly Suzhou Pharmaceutical Co., Ltd.; | 2023-9-18 |
欢迎光临 药群论坛 (http://yaoqun.net/) | Powered by Discuz! X3.2 |